ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025
Predictive utility of systemic inflammatory markers in differentiating laryngeal lesions.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLaryngeal lesions encompass both benign and malignant pathologies and present with symptoms ranging from hoarseness to throat pain. This study aimed to evaluate the predictive value of systemic inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammatory index (SII), systemic inflammatory response index (SIRI) and haemoglobin-albumin-lymphocyte-platelet (HALP) score, for distinguishing malignant from benign laryngeal lesions. STUDY
designSingle-center retrospective cross-sectional analysis.
settingTertiary medical institution.
methodsThis single-centre retrospective cross-sectional study analysed 442 patients presenting with hoarseness at a tertiary centre between 2020 and 2023. Based on their biopsy results, the patients were classified into four groups: benign lesions, low-grade dysplasia, high-grade dysplasia, and squamous cell carcinoma (SCC). Preoperative blood tests were used to calculate inflammatory markers. Statistical analyses included Kruskal-Wallis tests and post-hoc pairwise comparisons, with significance set at p < 0.05.
resultsThe SCC group demonstrated significantly higher median NLR, SII and SIRI values and lower LMR and HALP scores than the benign and dysplastic groups (p < 0.001). Among the indices, SIRI exhibited the highest predictive accuracy for SCC, with an AUC of 0.7, followed by NLR (0.681) and SII (0.672). HALP showed predictive value but was significant only between SCC and benign lesions. Multivariate logistic regression identified SII and LMR as predictive factors.
conclusionSystemic inflammatory markers, particularly SIRI, SII and LMR, hold promise as adjunctive diagnostic tools for assessing malignancy risk in laryngeal lesions. Although their standalone prognostic utility remains limited, these indices may improve clinical decision-making by identifying high-risk patients for earlier biopsy appointments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.